{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:06:21Z","timestamp":1792101981106,"version":"4.4.0"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s00404-017-4429-2","type":"journal-article","created":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:12:27Z","timestamp":1498090347000},"page":"405-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["Polycystic ovary syndrome, adipose tissue and metabolic syndrome"],"prefix":"10.1007","volume":"296","author":[{"given":"Alessandro P.","family":"Delitala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Delitala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Cherchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Dessole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,22]]},"reference":[{"key":"4429_CR1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.beem.2006.02.004","volume":"20","author":"BO Yildiz","year":"2006","unstructured":"Yildiz BO (2006) Diagnosis of hyperandrogenism: clinical criteria. Best Pract Res Clin Endocrinol Metab 20:167\u2013176","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4429_CR2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam EA-SPcwg","year":"2004","unstructured":"Rotterdam EA-SPcwg (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41\u201347","journal-title":"Hum Reprod"},{"key":"4429_CR3","first-page":"377","volume-title":"polycystic ovary syndrome","author":"JK Zawadski","year":"1992","unstructured":"Zawadski JK (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif AGJ, Haseltine FP, Merriam GR (eds) polycystic ovary syndrome. Blackwell Scientific Publications, Boston, pp 377\u2013384"},{"key":"4429_CR4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R (2006) Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91:781\u2013785","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR5","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/humrep\/dem202","volume":"22","author":"AM Fulghesu","year":"2007","unstructured":"Fulghesu AM, Angioni S, Frau E, Belosi C, Apa R, Mioni R et al (2007) Ultrasound in polycystic ovary syndrome\u2014the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Hum Reprod 22:2501\u20132508","journal-title":"Hum Reprod"},{"key":"4429_CR6","first-page":"599","volume":"24","author":"VL Kalinin","year":"1984","unstructured":"Kalinin VL, Suslova IN, Suslov AV (1984) Mutagenic effects of gamma-rays on plasmid DNA in Escherichia coli. Radiobiologiia 24:599\u2013602","journal-title":"Radiobiologiia"},{"key":"4429_CR7","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","volume":"83","author":"CM DeUgarte","year":"2005","unstructured":"DeUgarte CM, Bartolucci AA, Azziz R (2005) Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 83:1454\u20131460","journal-title":"Fertil Steril"},{"key":"4429_CR8","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1210\/jc.2004-1764","volume":"90","author":"RE Pelt Van","year":"2005","unstructured":"Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM (2005) Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab 90:4573\u20134578","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","volume":"21","author":"BL Wajchenberg","year":"2000","unstructured":"Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697\u2013738","journal-title":"Endocr Rev"},{"key":"4429_CR10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.beem.2006.02.005","volume":"20","author":"MO Goodarzi","year":"2006","unstructured":"Goodarzi MO, Azziz R (2006) Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 20:193\u2013205","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4429_CR11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA (2016) The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 37:467\u2013520","journal-title":"Endocr Rev"},{"key":"4429_CR12","first-page":"2304","volume":"85","author":"JK Wickenheisser","year":"2000","unstructured":"Wickenheisser JK, Quinn PG, Nelson VL, Legro RS, Strauss JF 3rd, McAllister JM (2000) Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells. J Clin Endocrinol Metab 85:2304\u20132311","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al (2009) The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91:456\u2013488","journal-title":"Fertil Steril"},{"key":"4429_CR14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","volume":"1","author":"MG Hull","year":"1987","unstructured":"Hull MG (1987) Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1:235\u2013245","journal-title":"Gynecol Endocrinol"},{"key":"4429_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1210\/jcem-72-1-83","volume":"72","author":"JE Nestler","year":"1991","unstructured":"Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS et al (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83\u201389","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/er.16.3.322","volume":"16","author":"DA Ehrmann","year":"1995","unstructured":"Ehrmann DA, Barnes RB, Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16:322\u2013353","journal-title":"Endocr Rev"},{"key":"4429_CR17","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"Diamanti-Kandarakis E, Dunaif A (2012) Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev 33:981\u20131030","journal-title":"Endocr Rev"},{"key":"4429_CR18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11154-007-9054-0","volume":"8","author":"BO Yildiz","year":"2007","unstructured":"Yildiz BO, Azziz R (2007) The adrenal and polycystic ovary syndrome. Rev Endocr Metab Disord 8:331\u2013342","journal-title":"Rev Endocr Metab Disord"},{"key":"4429_CR19","first-page":"1686","volume":"79","author":"RL Rosenfield","year":"1994","unstructured":"Rosenfield RL, Barnes RB, Ehrmann DA (1994) Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 79:1686\u20131692","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR20","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","volume":"86","author":"VL Nelson","year":"2001","unstructured":"Nelson VL, Qin KN, Rosenfield RL, Wood JR, Penning TM, Legro RS et al (2001) The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 86:5925\u20135933","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR21","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S1462399408000598","volume":"10","author":"E Diamanti-Kandarakis","year":"2008","unstructured":"Diamanti-Kandarakis E (2008) Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med 10:e3","journal-title":"Expert Rev Mol Med"},{"key":"4429_CR22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12958-016-0173-x","volume":"14","author":"V Leo De","year":"2016","unstructured":"De Leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F (2016) Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol 14:38","journal-title":"Reprod Biol Endocrinol"},{"key":"4429_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0889-8545(05)70184-4","volume":"28","author":"BN Kalro","year":"2001","unstructured":"Kalro BN, Loucks TL, Berga SL (2001) Neuromodulation in polycystic ovary syndrome. Obstet Gynecol Clin N Am 28:35\u201362","journal-title":"Obstet Gynecol Clin N Am"},{"key":"4429_CR24","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.2001.281.2.E392","volume":"281","author":"A Dunaif","year":"2001","unstructured":"Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E (2001) Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 281:E392\u2013E399","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4429_CR25","first-page":"577","volume":"75","author":"TP Ciaraldi","year":"1992","unstructured":"Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SS (1992) Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 75:577\u2013583","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR26","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2008.02.091","volume":"89","author":"AA Bremer","year":"2008","unstructured":"Bremer AA, Miller WL (2008) The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil Steril 89:1039\u20131048","journal-title":"Fertil Steril"},{"key":"4429_CR27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2008-1492","volume":"94","author":"TP Ciaraldi","year":"2009","unstructured":"Ciaraldi TP, Aroda V, Mudaliar S, Chang RJ, Henry RR (2009) Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. J Clin Endocrinol Metab 94:157\u2013163","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1210\/er.2002-0015","volume":"24","author":"V Leo De","year":"2003","unstructured":"De Leo V, la Marca A, Petraglia F (2003) Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 24:633\u2013667","journal-title":"Endocr Rev"},{"key":"4429_CR29","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0889-8529(05)70075-X","volume":"28","author":"RS Legro","year":"1999","unstructured":"Legro RS (1999) Polycystic ovary syndrome. Phenotype to genotype. Endocrinol Metab Clin N Am 28:379\u2013396","journal-title":"Endocrinol Metab Clin N Am"},{"key":"4429_CR30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","volume":"22","author":"DA Ehrmann","year":"1999","unstructured":"Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J (1999) Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22:141\u2013146","journal-title":"Diabetes Care"},{"key":"4429_CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","volume":"36","author":"DS Kiddy","year":"1992","unstructured":"Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ et al (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36:105\u2013111","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4429_CR32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/BF03345266","volume":"26","author":"E Carmina","year":"2003","unstructured":"Carmina E (2003) Genetic and environmental aspect of polycystic ovary syndrome. J Endocrinol Investig 26:1151\u20131159","journal-title":"J Endocrinol Investig"},{"issue":"Suppl 1","key":"4429_CR33","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.fertnstert.2006.03.012","volume":"86","author":"E Carmina","year":"2006","unstructured":"Carmina E, Azziz R (2006) Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril 86(Suppl 1):S7\u2013S8","journal-title":"Fertil Steril"},{"key":"4429_CR34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","volume":"26","author":"A Gambineri","year":"2002","unstructured":"Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R (2002) Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26:883\u2013896","journal-title":"Int J Obes Relat Metab Disord"},{"key":"4429_CR35","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2007-2117","volume":"93","author":"TM Barber","year":"2008","unstructured":"Barber TM, Golding SJ, Alvey C, Wass JA, Karpe F, Franks S et al (2008) Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. J Clin Endocrinol Metab 93:999\u20131004","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1196\/annals.1365.014","volume":"1092","author":"R Pasquali","year":"2006","unstructured":"Pasquali R, Gambineri A (2006) Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann N Y Acad Sci 1092:158\u2013174","journal-title":"Ann N Y Acad Sci"},{"key":"4429_CR37","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(99)00641-X","volume":"73","author":"SJ Winters","year":"2000","unstructured":"Winters SJ, Talbott E, Guzick DS, Zborowski J, McHugh KP (2000) Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. Fertil Steril 73:724\u2013729","journal-title":"Fertil Steril"},{"key":"4429_CR38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1365-2265.1996.676498.x","volume":"44","author":"MA Birdsall","year":"1996","unstructured":"Birdsall MA, Farquhar CM (1996) Polycystic ovaries in pre and post-menopausal women. Clin Endocrinol (Oxf) 44:269\u2013276","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4429_CR39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","volume":"109","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart A et al (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition. Circulation 109:433\u2013438","journal-title":"Circulation"},{"key":"4429_CR40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"JP Despres","year":"2006","unstructured":"Despres JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881\u2013887","journal-title":"Nature"},{"key":"4429_CR41","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diabetes.49.12.2094","volume":"49","author":"C Weyer","year":"2000","unstructured":"Weyer C, Hanson RL, Tataranni PA, Bogardus C, Pratley RE (2000) A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 49:2094\u20132101","journal-title":"Diabetes"},{"key":"4429_CR42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF01225573","volume":"8","author":"W Leonhardt","year":"1972","unstructured":"Leonhardt W, Hanefeld M, Schneider H, Haller H (1972) Human adipocyte volumes: maximum size, and correlation to weight index in maturity onset-diabetes. Diabetologia 8:287\u2013291","journal-title":"Diabetologia"},{"key":"4429_CR43","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","volume":"16","author":"S Kirchengast","year":"2001","unstructured":"Kirchengast S, Huber J (2001) Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 16:1255\u20131260","journal-title":"Hum Reprod"},{"key":"4429_CR44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajpa.10364","volume":"124","author":"R Horejsi","year":"2004","unstructured":"Horejsi R, Moller R, Rackl S, Giuliani A, Freytag U, Crailsheim K et al (2004) Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women. Am J Phys Anthropol 124:275\u2013281","journal-title":"Am J Phys Anthropol"},{"key":"4429_CR45","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/EJE-07-0515","volume":"158","author":"S Cupisti","year":"2008","unstructured":"Cupisti S, Kajaia N, Dittrich R, Duezenli H, Beckmann MW, Mueller A (2008) Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome. Eur J Endocrinol 158:711\u2013719","journal-title":"Eur J Endocrinol"},{"key":"4429_CR46","first-page":"165","volume":"84","author":"RS Legro","year":"1999","unstructured":"Legro RS, Kunselman AR, Dodson WC, Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165\u2013169","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR47","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.fertnstert.2004.06.040","volume":"82","author":"D Glintborg","year":"2004","unstructured":"Glintborg D, Henriksen JE, Andersen M, Hagen C, Hangaard J, Rasmussen PE et al (2004) Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis. Fertil Steril 82:1570\u20131579","journal-title":"Fertil Steril"},{"key":"4429_CR48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","volume":"156","author":"ED Rosen","year":"2014","unstructured":"Rosen ED, Spiegelman BM (2014) What we talk about when we talk about fat. Cell 156:20\u201344","journal-title":"Cell"},{"key":"4429_CR49","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/diabetes.51.2.484","volume":"51","author":"I Ek","year":"2002","unstructured":"Ek I, Arner P, Ryden M, Holm C, Thorne A, Hoffstedt J et al (2002) A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes 51:484\u2013492","journal-title":"Diabetes"},{"key":"4429_CR50","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI114880","volume":"86","author":"P Arner","year":"1990","unstructured":"Arner P, Hellstrom L, Wahrenberg H, Bronnegard M (1990) Beta-adrenoceptor expression in human fat cells from different regions. J Clin Investig 86:1595\u20131600","journal-title":"J Clin Investig"},{"key":"4429_CR51","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1476-5381.1993.tb13902.x","volume":"110","author":"F Lonnqvist","year":"1993","unstructured":"Lonnqvist F, Krief S, Strosberg AD, Nyberg S, Emorine LJ, Arner P (1993) Evidence for a functional beta 3-adrenoceptor in man. Br J Pharmacol 110:929\u2013936","journal-title":"Br J Pharmacol"},{"key":"4429_CR52","doi-asserted-by":"crossref","first-page":"d169","DOI":"10.2741\/A272","volume":"3","author":"G Boden","year":"1998","unstructured":"Boden G (1998) Free fatty acids (FFA), a link between obesity and insulin resistance. Front Biosci 3:d169\u2013d175","journal-title":"Front Biosci"},{"key":"4429_CR53","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00125-003-1228-z","volume":"46","author":"M Fasshauer","year":"2003","unstructured":"Fasshauer M, Paschke R (2003) Regulation of adipocytokines and insulin resistance. Diabetologia 46:1594\u20131603","journal-title":"Diabetologia"},{"key":"4429_CR54","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0083-6729(06)74018-3","volume":"74","author":"JN Fain","year":"2006","unstructured":"Fain JN (2006) Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 74:443\u2013477","journal-title":"Vitam Horm"},{"key":"4429_CR55","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1055\/s-2002-38265","volume":"34","author":"C Belanger","year":"2002","unstructured":"Belanger C, Luu-The V, Dupont P, Tchernof A (2002) Adipose tissue intracrinology: potential importance of local androgen\/estrogen metabolism in the regulation of adiposity. Horm Metab Res 34:737\u2013745","journal-title":"Horm Metab Res"},{"key":"4429_CR56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1055\/s-2002-38249","volume":"34","author":"A Meseguer","year":"2002","unstructured":"Meseguer A, Puche C, Cabero A (2002) Sex steroid biosynthesis in white adipose tissue. Horm Metab Res 34:731\u2013736","journal-title":"Horm Metab Res"},{"key":"4429_CR57","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tem.2004.09.007","volume":"15","author":"JR Seckl","year":"2004","unstructured":"Seckl JR, Walker BR (2004) 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends Endocrinol Metab 15:418\u2013424","journal-title":"Trends Endocrinol Metab"},{"key":"4429_CR58","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1210\/jc.2003-031157","volume":"89","author":"M Lundgren","year":"2004","unstructured":"Lundgren M, Buren J, Ruge T, Myrnas T, Eriksson JW (2004) Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes. J Clin Endocrinol Metab 89:2989\u20132997","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR59","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0303-7207(97)00118-4","volume":"132","author":"AE Michael","year":"1997","unstructured":"Michael AE, Evagelatou M, Norgate DP, Clarke RJ, Antoniw JW, Stedman BA et al (1997) Isoforms of 11beta-hydroxysteroid dehydrogenase in human granulosa-lutein cells. Mol Cell Endocrinol 132:43\u201352","journal-title":"Mol Cell Endocrinol"},{"key":"4429_CR60","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1210\/jc.2003-030286","volume":"88","author":"DJ Wake","year":"2003","unstructured":"Wake DJ, Rask E, Livingstone DE, Soderberg S, Olsson T, Walker BR (2003) Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab 88:3983\u20133988","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR61","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1210\/jc.2003-032240","volume":"89","author":"G Valsamakis","year":"2004","unstructured":"Valsamakis G, Anwar A, Tomlinson JW, Shackleton CH, McTernan PG, Chetty R et al (2004) 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. J Clin Endocrinol Metab 89:4755\u20134761","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR62","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","volume":"294","author":"H Masuzaki","year":"2001","unstructured":"Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166\u20132170","journal-title":"Science"},{"key":"4429_CR63","first-page":"3330","volume":"87","author":"E Rask","year":"2002","unstructured":"Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O et al (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87:3330\u20133336","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/humupd\/dmp005","volume":"15","author":"G Fanciulli","year":"2009","unstructured":"Fanciulli G, Delitala A, Delitala G (2009) Growth hormone, menopause and ageing: no definite evidence for \u2018rejuvenation\u2019 with growth hormone. Hum Reprod Update 15:341\u2013358","journal-title":"Hum Reprod Update"},{"key":"4429_CR65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2362.1993.tb00762.x","volume":"23","author":"RJ Brummer","year":"1993","unstructured":"Brummer RJ, Lonn L, Kvist H, Grangard U, Bengtsson BA, Sjostrom L (1993) Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and 1\u00a0year after adenomectomy. Eur J Clin Investig 23:199\u2013205","journal-title":"Eur J Clin Investig"},{"key":"4429_CR66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(97)04503-0","volume":"350","author":"P Bjorntorp","year":"1997","unstructured":"Bjorntorp P (1997) Obesity. Lancet 350:423\u2013426","journal-title":"Lancet"},{"key":"4429_CR67","first-page":"E467","volume":"263","author":"M Beauville","year":"1992","unstructured":"Beauville M, Harant I, Crampes F, Riviere D, Tauber MT, Tauber JP et al (1992) Effect of long-term rhGH administration in GH-deficient adults on fat cell epinephrine response. Am J Physiol 263:E467\u2013E472","journal-title":"Am J Physiol"},{"key":"4429_CR68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0025-7125(16)30696-4","volume":"73","author":"AR Glass","year":"1989","unstructured":"Glass AR (1989) Endocrine aspects of obesity. Med Clin N Am 73:139\u2013160","journal-title":"Med Clin N Am"},{"key":"4429_CR69","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1532-5415.1985.tb04195.x","volume":"33","author":"D Rudman","year":"1985","unstructured":"Rudman D (1985) Growth hormone, body composition, and aging. J Am Geriatr Soc 33:800\u2013807","journal-title":"J Am Geriatr Soc"},{"key":"4429_CR70","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1210\/jcem.82.11.4388","volume":"82","author":"N Vahl","year":"1997","unstructured":"Vahl N, Moller N, Lauritzen T, Christiansen JS, Jorgensen JO (1997) Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. J Clin Endocrinol Metab 82:3612\u20133618","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR71","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1210\/jcem.86.8.7731","volume":"86","author":"JL Clasey","year":"2001","unstructured":"Clasey JL, Weltman A, Patrie J, Weltman JY, Pezzoli S, Bouchard C et al (2001) Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J Clin Endocrinol Metab 86:3845\u20133852","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR72","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/en.2003-1336","volume":"145","author":"JN Fain","year":"2004","unstructured":"Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145:2273\u20132282","journal-title":"Endocrinology"},{"key":"4429_CR73","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","volume":"395","author":"JM Friedman","year":"1998","unstructured":"Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Nature 395:763\u2013770","journal-title":"Nature"},{"key":"4429_CR74","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1753-4887.1998.tb01764.x","volume":"56","author":"MB Zemel","year":"1998","unstructured":"Zemel MB (1998) Agouti\/melanocortin interactions with leptin pathways in obesity. Nutr Rev 56:271\u2013274","journal-title":"Nutr Rev"},{"key":"4429_CR75","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1210\/jcem.87.5.8628","volume":"87","author":"M Rosenbaum","year":"2002","unstructured":"Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL (2002) Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 87:2391\u20132394","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR76","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/rp.59.1.305","volume":"59","author":"C Bjorbaek","year":"2004","unstructured":"Bjorbaek C, Kahn BB (2004) Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59:305\u2013331","journal-title":"Recent Prog Horm Res"},{"key":"4429_CR77","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(03)01081-X","volume":"116","author":"JS Flier","year":"2004","unstructured":"Flier JS (2004) Obesity wars: molecular progress confronts an expanding epidemic. Cell 116:337\u2013350","journal-title":"Cell"},{"key":"4429_CR78","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","volume":"282","author":"SB Heymsfield","year":"1999","unstructured":"Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T et al (1999) Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282:1568\u20131575","journal-title":"JAMA"},{"key":"4429_CR79","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(96)03173-X","volume":"348","author":"JF Caro","year":"1996","unstructured":"Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH et al (1996) Decreased cerebrospinal-fluid\/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159\u2013161","journal-title":"Lancet"},{"key":"4429_CR80","doi-asserted-by":"crossref","first-page":"30059","DOI":"10.1074\/jbc.274.42.30059","volume":"274","author":"C Bjorbaek","year":"1999","unstructured":"Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS (1999) The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 274:30059\u201330065","journal-title":"J Biol Chem"},{"key":"4429_CR81","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00404-010-1432-2","volume":"282","author":"G Capobianco","year":"2010","unstructured":"Capobianco G, de Muro P, Cherchi GM, Formato M, Lepedda AJ, Cigliano A et al (2010) Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles. Arch Gynecol Obstet 282:207\u2013213","journal-title":"Arch Gynecol Obstet"},{"key":"4429_CR82","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.beem.2005.07.008","volume":"19","author":"A Koerner","year":"2005","unstructured":"Koerner A, Kratzsch J, Kiess W (2005) Adipocytokines: leptin\u2014the classical, resistin\u2014the controversical, adiponectin\u2014the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19:525\u2013546","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4429_CR83","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/01.hjh.0000222743.06584.66","volume":"24","author":"J Beltowski","year":"2006","unstructured":"Beltowski J (2006) Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens 24:789\u2013801","journal-title":"J Hypertens"},{"key":"4429_CR84","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2249.2006.03025.x","volume":"143","author":"M Karaduman","year":"2006","unstructured":"Karaduman M, Oktenli C, Musabak U, Sengul A, Yesilova Z, Cingoz F et al (2006) Leptin, soluble interleukin-6 receptor, C-reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atherosclerotic plaque. Clin Exp Immunol 143:452\u2013457","journal-title":"Clin Exp Immunol"},{"key":"4429_CR85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2006.03.003","volume":"189","author":"J Beltowski","year":"2006","unstructured":"Beltowski J (2006) Leptin and atherosclerosis. Atherosclerosis 189:47\u201360","journal-title":"Atherosclerosis"},{"key":"4429_CR86","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1161\/ATVBAHA.107.148353","volume":"27","author":"P Singh","year":"2007","unstructured":"Singh P, Hoffmann M, Wolk R, Shamsuzzaman AS, Somers VK (2007) Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 27:e302\u2013e307","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4429_CR87","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ncpcardio1218","volume":"5","author":"A Romero-Corral","year":"2008","unstructured":"Romero-Corral A, Sierra-Johnson J, Lopez-Jimenez F, Thomas RJ, Singh P, Hoffmann M et al (2008) Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med 5:418\u2013425","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"4429_CR88","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1161\/hc5001.101061","volume":"104","author":"AM Wallace","year":"2001","unstructured":"Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A et al (2001) Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052\u20133056","journal-title":"Circulation"},{"key":"4429_CR89","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1073\/pnas.0308767101","volume":"101","author":"J Licinio","year":"2004","unstructured":"Licinio J, Caglayan S, Ozata M, Yildiz BO, de Miranda PB, O\u2019Kirwan F et al (2004) Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci USA 101:4531\u20134536","journal-title":"Proc Natl Acad Sci USA"},{"key":"4429_CR90","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","volume":"346","author":"EA Oral","year":"2002","unstructured":"Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P et al (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570\u2013578","journal-title":"N Engl J Med"},{"key":"4429_CR91","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1590\/S0100-879X2011000500001","volume":"44","author":"SB Lecke","year":"2011","unstructured":"Lecke SB, Morsch DM, Spritzer PM (2011) Leptin and adiponectin in the female life course. Braz J Med Biol Res 44:381\u2013387","journal-title":"Braz J Med Biol Res"},{"key":"4429_CR92","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.4238\/2013.February.28.16","volume":"12","author":"SB Lecke","year":"2013","unstructured":"Lecke SB, Morsch DM, Spritzer PM (2013) Association between adipose tissue expression and serum levels of leptin and adiponectin in women with polycystic ovary syndrome. Genet Mol Res 12:4292\u20134296","journal-title":"Genet Mol Res"},{"key":"4429_CR93","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/s-2005-861173","volume":"37","author":"PM Spritzer","year":"2005","unstructured":"Spritzer PM, Comim FV, Capp E, D\u2019Avila A (2005) Influence of leptin, androgens and insulin sensitivity on increased GH response to clonidine in lean patients with polycystic ovary syndrome. Horm Metab Res 37:94\u201398","journal-title":"Horm Metab Res"},{"key":"4429_CR94","doi-asserted-by":"crossref","first-page":"E1891","DOI":"10.1210\/jc.2013-2227","volume":"98","author":"BK Tan","year":"2013","unstructured":"Tan BK, Chen J, Hu J, Amar O, Mattu HS, Adya R et al (2013) Metformin increases the novel adipokine cartonectin\/CTRP3 in women with polycystic ovary syndrome. J Clin Endocrinol Metab 98:E1891\u2013E1900","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR95","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.jbchem.a021483","volume":"120","author":"Y Nakano","year":"1996","unstructured":"Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M (1996) Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 120:803\u2013812","journal-title":"J Biochem"},{"key":"4429_CR96","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.1074\/jbc.271.18.10697","volume":"271","author":"E Hu","year":"1996","unstructured":"Hu E, Liang P, Spiegelman BM (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697\u201310703","journal-title":"J Biol Chem"},{"key":"4429_CR97","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","volume":"257","author":"Y Arita","year":"1999","unstructured":"Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79\u201383","journal-title":"Biochem Biophys Res Commun"},{"key":"4429_CR98","doi-asserted-by":"crossref","first-page":"26746","DOI":"10.1074\/jbc.270.45.26746","volume":"270","author":"PE Scherer","year":"1995","unstructured":"Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746\u201326749","journal-title":"J Biol Chem"},{"key":"4429_CR99","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439\u2013451","journal-title":"Endocr Rev"},{"key":"4429_CR100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.ATV.0000099786.99623.EF","volume":"24","author":"Y Matsuzawa","year":"2004","unstructured":"Matsuzawa Y, Funahashi T, Kihara S, Shimomura I (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24:29\u201333","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4429_CR101","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/er.2006-0033","volume":"27","author":"ME Trujillo","year":"2006","unstructured":"Trujillo ME, Scherer PE (2006) Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27:762\u2013778","journal-title":"Endocr Rev"},{"key":"4429_CR102","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1210\/jc.2004-1980","volume":"90","author":"MB Chen","year":"2005","unstructured":"Chen MB, McAinch AJ, Macaulay SL, Castelli LA, O\u2019Brien PE, Dixon JB et al (2005) Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90:3665\u20133672","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR103","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1210\/jc.2004-0303","volume":"89","author":"A Bottner","year":"2004","unstructured":"Bottner A, Kratzsch J, Muller G, Kapellen TM, Bluher S, Keller E et al (2004) Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 89:4053\u20134061","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR104","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ijcard.2007.12.087","volume":"134","author":"A Coppola","year":"2009","unstructured":"Coppola A, Marfella R, Coppola L, Tagliamonte E, Fontana D, Liguori E et al (2009) Effect of weight loss on coronary circulation and adiponectin levels in obese women. Int J Cardiol 134:414\u2013416","journal-title":"Int J Cardiol"},{"key":"4429_CR105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/diabetes.51.1.37","volume":"51","author":"M Stumvoll","year":"2002","unstructured":"Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M et al (2002) Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51:37\u201341","journal-title":"Diabetes"},{"key":"4429_CR106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11892-003-0039-4","volume":"3","author":"F Vasseur","year":"2003","unstructured":"Vasseur F, Lepretre F, Lacquemant C, Froguel P (2003) The genetics of adiponectin. Curr Diab Rep 3:151\u2013158","journal-title":"Curr Diab Rep"},{"key":"4429_CR107","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cytogfr.2007.04.007","volume":"18","author":"F Lago","year":"2007","unstructured":"Lago F, Dieguez C, Gomez-Reino J, Gualillo O (2007) The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 18:313\u2013325","journal-title":"Cytokine Growth Factor Rev"},{"key":"4429_CR108","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/diacare.25.6.971","volume":"25","author":"T Kazumi","year":"2002","unstructured":"Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G (2002) Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25:971\u2013976","journal-title":"Diabetes Care"},{"key":"4429_CR109","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1291\/hypres.28.141","volume":"28","author":"M Furuhashi","year":"2005","unstructured":"Furuhashi M, Ura N, Higashiura K, Miyazaki Y, Murakami H, Hyakukoku M et al (2005) Low adiponectin level in young normotensive men with a family history of essential hypertension. Hypertens Res 28:141\u2013146","journal-title":"Hypertens Res"},{"key":"4429_CR110","first-page":"10","volume":"16","author":"HS Lee","year":"2007","unstructured":"Lee HS, Lee M, Joung H (2007) Adiponectin represents an independent risk factor for hypertension in middle aged Korean women. Asia Pac J Clin Nutr 16:10\u201315","journal-title":"Asia Pac J Clin Nutr"},{"key":"4429_CR111","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/HYPERTENSIONAHA.107.086835","volume":"49","author":"WS Chow","year":"2007","unstructured":"Chow WS, Cheung BM, Tso AW, Xu A, Wat NM, Fong CH et al (2007) Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study. Hypertension 49:1455\u20131461","journal-title":"Hypertension"},{"key":"4429_CR112","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1291\/hypres.31.229","volume":"31","author":"T Imatoh","year":"2008","unstructured":"Imatoh T, Miyazaki M, Momose Y, Tanihara S, Une H (2008) Adiponectin levels associated with the development of hypertension: a prospective study. Hypertens Res 31:229\u2013233","journal-title":"Hypertens Res"},{"key":"4429_CR113","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1001\/jama.291.14.1730","volume":"291","author":"T Pischon","year":"2004","unstructured":"Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291:1730\u20131737","journal-title":"JAMA"},{"key":"4429_CR114","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/eurheartj\/ehl361","volume":"28","author":"R Wolk","year":"2007","unstructured":"Wolk R, Berger P, Lennon RJ, Brilakis ES, Davison DE, Somers VK (2007) Association between plasma adiponectin levels and unstable coronary syndromes. Eur Heart J 28:292\u2013298","journal-title":"Eur Heart J"},{"key":"4429_CR115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tcm.2006.03.001","volume":"16","author":"N Ouchi","year":"2006","unstructured":"Ouchi N, Shibata R, Walsh K (2006) Cardioprotection by adiponectin. Trends Cardiovasc Med 16:141\u2013146","journal-title":"Trends Cardiovasc Med"},{"key":"4429_CR116","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/oby.2005.74","volume":"13","author":"M Degawa-Yamauchi","year":"2005","unstructured":"Degawa-Yamauchi M, Moss KA, Bovenkerk JE, Shankar SS, Morrison CL, Lelliott CJ et al (2005) Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 13:662\u2013669","journal-title":"Obes Res"},{"key":"4429_CR117","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","volume":"102","author":"N Ouchi","year":"2000","unstructured":"Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H et al (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102:1296\u20131301","journal-title":"Circulation"},{"key":"4429_CR118","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.bbrc.2006.03.010","volume":"343","author":"H Sell","year":"2006","unstructured":"Sell H, Dietze-Schroeder D, Eckardt K, Eckel J (2006) Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazone. Biochem Biophys Res Commun 343:700\u2013706","journal-title":"Biochem Biophys Res Commun"},{"key":"4429_CR119","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.bbrc.2005.04.026","volume":"331","author":"L Nilsson","year":"2005","unstructured":"Nilsson L, Binart N, Bohlooly YM, Bramnert M, Egecioglu E, Kindblom J et al (2005) Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem Biophys Res Commun 331:1120\u20131126","journal-title":"Biochem Biophys Res Commun"},{"key":"4429_CR120","doi-asserted-by":"crossref","first-page":"18073","DOI":"10.1074\/jbc.M414231200","volume":"280","author":"A Xu","year":"2005","unstructured":"Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J et al (2005) Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 280:18073\u201318080","journal-title":"J Biol Chem"},{"key":"4429_CR121","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/endo.143.3.8662","volume":"143","author":"TP Combs","year":"2002","unstructured":"Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB et al (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143:998\u20131007","journal-title":"Endocrinology"},{"key":"4429_CR122","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.bbrc.2006.05.033","volume":"345","author":"IB Bauche","year":"2006","unstructured":"Bauche IB, Ait El Mkadem S, Rezsohazy R, Funahashi T, Maeda N, Miranda LM et al (2006) Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice. Biochem Biophys Res Commun 345:1414\u20131424","journal-title":"Biochem Biophys Res Commun"},{"key":"4429_CR123","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1210\/jc.2005-0615","volume":"90","author":"D Glintborg","year":"2005","unstructured":"Glintborg D, Stoving RK, Hagen C, Hermann AP, Frystyk J, Veldhuis JD et al (2005) Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome. J Clin Endocrinol Metab 90:5605\u20135612","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR124","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","volume":"15","author":"KA Toulis","year":"2009","unstructured":"Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC et al (2009) Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 15:297\u2013307","journal-title":"Hum Reprod Update"},{"key":"4429_CR125","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1007\/s13277-013-1595-0","volume":"35","author":"S Li","year":"2014","unstructured":"Li S, Huang X, Zhong H, Peng Q, Chen S, Xie Y et al (2014) Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis. Tumour Biol 35:3961\u20133973","journal-title":"Tumour Biol"},{"key":"4429_CR126","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1365-2265.2004.02159.x","volume":"61","author":"J Spranger","year":"2004","unstructured":"Spranger J, Mohlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T et al (2004) Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 61:738\u2013746","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4429_CR127","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/13813455.2016.1190760","volume":"122","author":"DI Koleva","year":"2016","unstructured":"Koleva DI, Orbetzova MM, Nikolova JG, Tyutyundzhiev SB (2016) Adipokines and soluble cell adhesion molecules in insulin resistant and non-insulin resistant women with polycystic ovary syndrome. Arch Physiol Biochem 122:223\u2013227","journal-title":"Arch Physiol Biochem"},{"key":"4429_CR128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/2042018811423770","volume":"2","author":"B Pangaribuan","year":"2011","unstructured":"Pangaribuan B, Yusuf I, Mansyur M, Wijaya A (2011) Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Ther Adv Endocrinol Metab 2:235\u2013245","journal-title":"Ther Adv Endocrinol Metab"},{"key":"4429_CR129","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00125-006-0419-9","volume":"49","author":"BK Tan","year":"2006","unstructured":"Tan BK, Chen J, Digby JE, Keay SD, Kennedy CR, Randeva HS (2006) Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome. Diabetologia 49:2723\u20132728","journal-title":"Diabetologia"},{"key":"4429_CR130","doi-asserted-by":"crossref","first-page":"e80416","DOI":"10.1371\/journal.pone.0080416","volume":"8","author":"FV Comim","year":"2013","unstructured":"Comim FV, Hardy K, Franks S (2013) Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. PLoS One 8:e80416","journal-title":"PLoS One"},{"key":"4429_CR131","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2004-0463","volume":"89","author":"L Ibanez","year":"2004","unstructured":"Ibanez L, Valls C, Marcos MV, Ong K, Dunger DB, De Zegher F (2004) Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab 89:4331\u20134337","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR132","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s11596-010-0556-8","volume":"30","author":"Y Wang","year":"2010","unstructured":"Wang Y, Xie X, Zhu W (2010) Serum adiponectin and resistin levels in patients with polycystic ovarian syndrome and their clinical implications. J Huazhong Univ Sci Technol Med Sci 30:638\u2013642","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"key":"4429_CR133","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/09513590802653833","volume":"25","author":"M Yilmaz","year":"2009","unstructured":"Yilmaz M, Bukan N, Demirci H, Ozturk C, Kan E, Ayvaz G et al (2009) Serum resistin and adiponectin levels in women with polycystic ovary syndrome. Gynecol Endocrinol 25:246\u2013252","journal-title":"Gynecol Endocrinol"},{"key":"4429_CR134","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/09513590903247816","volume":"26","author":"S Arikan","year":"2010","unstructured":"Arikan S, Bahceci M, Tuzcu A, Kale E, Gokalp D (2010) Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome. Gynecol Endocrinol 26:161\u2013166","journal-title":"Gynecol Endocrinol"},{"key":"4429_CR135","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","volume":"307","author":"A Fukuhara","year":"2005","unstructured":"Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426\u2013430","journal-title":"Science"},{"key":"4429_CR136","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.fertnstert.2009.04.055","volume":"94","author":"E Plati","year":"2010","unstructured":"Plati E, Kouskouni E, Malamitsi-Puchner A, Boutsikou M, Kaparos G, Baka S (2010) Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation. Fertil Steril 94:1451\u20131456","journal-title":"Fertil Steril"},{"key":"4429_CR137","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2362.2011.02586.x","volume":"42","author":"TK Lajunen","year":"2012","unstructured":"Lajunen TK, Purhonen AK, Haapea M, Ruokonen A, Puukka K, Hartikainen AL et al (2012) Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome. Eur J Clin Investig 42:321\u2013328","journal-title":"Eur J Clin Investig"},{"key":"4429_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09513590.2017.1296425","volume":"16","author":"K Dambala","year":"2017","unstructured":"Dambala K, Vavilis D, Bili E, Goulis DG, Tarlatzis BC (2017) Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome. Gynecol Endocrinol 16:1\u20135. doi: 10.1080\/09513590.2017.1296425","journal-title":"Gynecol Endocrinol"},{"key":"4429_CR139","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1079\/PNS2001110","volume":"60","author":"SW Coppack","year":"2001","unstructured":"Coppack SW (2001) Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60:349\u2013356","journal-title":"Proc Nutr Soc"},{"key":"4429_CR140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87\u201391","journal-title":"Science"},{"key":"4429_CR141","first-page":"859","volume":"83","author":"A Katsuki","year":"1998","unstructured":"Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K et al (1998) Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859\u2013862","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR142","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1359-6101(03)00052-2","volume":"14","author":"H Ruan","year":"2003","unstructured":"Ruan H, Lodish HF (2003) Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev 14:447\u2013455","journal-title":"Cytokine Growth Factor Rev"},{"key":"4429_CR143","first-page":"270","volume":"29","author":"CE Juge-Aubry","year":"2005","unstructured":"Juge-Aubry CE, Somm E, Pernin A, Alizadeh N, Giusti V, Dayer JM et al (2005) Adipose tissue is a regulated source of interleukin-10. Cytokine 29:270\u2013274","journal-title":"Cytokine"},{"key":"4429_CR144","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","volume":"106","author":"K Esposito","year":"2002","unstructured":"Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M et al (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067\u20132072","journal-title":"Circulation"},{"key":"4429_CR145","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.2337\/db05-1421","volume":"55","author":"I Dahlman","year":"2006","unstructured":"Dahlman I, Forsgren M, Sjogren A, Nordstrom EA, Kaaman M, Naslund E et al (2006) Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha. Diabetes 55:1792\u20131799","journal-title":"Diabetes"},{"key":"4429_CR146","first-page":"165","volume":"48","author":"NC Sayin","year":"2003","unstructured":"Sayin NC, Gucer F, Balkanli-Kaplan P, Yuce MA, Ciftci S, Kucuk M et al (2003) Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome. J Reprod Med 48:165\u2013170","journal-title":"J Reprod Med"},{"key":"4429_CR147","first-page":"419","volume":"13","author":"AV Araya","year":"2002","unstructured":"Araya AV, Aguirre A, Romero C, Miranda C, Molina MC, Ferreira A (2002) Evaluation of tumor necrosis factor alpha production in ex vivo short term cultured whole blood from women with polycystic ovary syndrome. Eur Cytokine Netw 13:419\u2013424","journal-title":"Eur Cytokine Netw"},{"key":"4429_CR148","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejogrb.2006.10.037","volume":"133","author":"M Olszanecka-Glinianowicz","year":"2007","unstructured":"Olszanecka-Glinianowicz M, Banas M, Zahorska-Markiewicz B, Janowska J, Kocelak P, Madej P et al (2007) Is the polycystic ovary syndrome associated with chronic inflammation per se? Eur J Obstet Gynecol Reprod Biol 133:197\u2013202","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"4429_CR149","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","volume":"48","author":"F Gonzalez","year":"1999","unstructured":"Gonzalez F, Thusu K, Abdel-Rahman E, Prabhala A, Tomani M, Dandona P (1999) Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Metabolism 48:437\u2013441","journal-title":"Metabolism"},{"key":"4429_CR150","doi-asserted-by":"crossref","first-page":"e0164021","DOI":"10.1371\/journal.pone.0164021","volume":"11","author":"L Gao","year":"2016","unstructured":"Gao L, Gu Y, Yin X (2016) High serum tumor necrosis factor-alpha levels in women with polycystic ovary syndrome: a meta-analysis. PLoS One 11:e0164021","journal-title":"PLoS One"},{"key":"4429_CR151","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2265.2009.03523.x","volume":"71","author":"D Glintborg","year":"2009","unstructured":"Glintborg D, Andersen M, Richelsen B, Bruun JM (2009) Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment. Clin Endocrinol (Oxf) 71:652\u2013658","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4429_CR152","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","volume":"90","author":"RS Legro","year":"2005","unstructured":"Legro RS, Gnatuk CL, Kunselman AR, Dunaif A (2005) Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 90:3236\u20133242","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR153","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","volume":"16","author":"RJ Norman","year":"2001","unstructured":"Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ (2001) Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 16:1995\u20131998","journal-title":"Hum Reprod"},{"key":"4429_CR154","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2012-1690","volume":"97","author":"CL Morgan","year":"2012","unstructured":"Morgan CL, Jenkins-Jones S, Currie CJ, Rees DA (2012) Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab 97:3251\u20133260","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/met.2008.0015","volume":"6","author":"F Mirzaei","year":"2008","unstructured":"Mirzaei F, Kazemi N (2008) Prevalence of polycystic ovary syndrome in women with type 2 diabetes in Kerman, Iran. Metab Syndr Relat Disord 6:215\u2013217","journal-title":"Metab Syndr Relat Disord"},{"key":"4429_CR156","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.fertnstert.2016.06.040","volume":"106","author":"SY Sim","year":"2016","unstructured":"Sim SY, Chin SL, Tan JL, Brown SJ, Cussons AJ, Stuckey BG (2016) Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype? Fertil Steril 106:1258\u20131263","journal-title":"Fertil Steril"},{"key":"4429_CR157","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2174\/157339911797579142","volume":"7","author":"N Mendoza","year":"2011","unstructured":"Mendoza N (2011) Common genetic aspects between polycystic ovary syndrome and diabetes mellitus. Curr Diabetes Rev 7:377\u2013391","journal-title":"Curr Diabetes Rev"},{"key":"4429_CR158","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00592-012-0383-4","volume":"50","author":"R Saxena","year":"2013","unstructured":"Saxena R, Welt CK (2013) Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes. Acta Diabetol 50:451\u2013457","journal-title":"Acta Diabetol"},{"key":"4429_CR159","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diacare.24.6.1050","volume":"24","author":"HR Peppard","year":"2001","unstructured":"Peppard HR, Marfori J, Iuorno MJ, Nestler JE (2001) Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diabetes Care 24:1050\u20131052","journal-title":"Diabetes Care"},{"key":"4429_CR160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.fertnstert.2006.01.019","volume":"86","author":"F Kelestimur","year":"2006","unstructured":"Kelestimur F, Unluhizarci K, Baybuga H, Atmaca H, Bayram F, Sahin Y (2006) Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus. Fertil Steril 86:405\u2013410","journal-title":"Fertil Steril"},{"key":"4429_CR161","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1001\/jama.289.22.3000","volume":"289","author":"JM Clark","year":"2003","unstructured":"Clark JM, Diehl AM (2003) Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 289:3000\u20133004","journal-title":"JAMA"},{"key":"4429_CR162","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","volume":"42","author":"G Bedogni","year":"2005","unstructured":"Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42:44\u201352","journal-title":"Hepatology"},{"key":"4429_CR163","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1746.2008.05740.x","volume":"24","author":"MM Brzozowska","year":"2009","unstructured":"Brzozowska MM, Ostapowicz G, Weltman MD (2009) An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. J Gastroenterol Hepatol 24:243\u2013247","journal-title":"J Gastroenterol Hepatol"},{"key":"4429_CR164","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","volume":"91","author":"TL Setji","year":"2006","unstructured":"Setji TL, Holland ND, Sanders LL, Pereira KC, Diehl AM, Brown AJ (2006) Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:1741\u20131747","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.14310\/horm.2002.1236","volume":"8","author":"F Economou","year":"2009","unstructured":"Economou F, Xyrafis X, Livadas S, Androulakis II, Argyrakopoulou G, Christakou CD et al (2009) In overweight\/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls. Hormones (Athens) 8:199\u2013206","journal-title":"Hormones (Athens)"},{"key":"4429_CR166","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.14.185","volume":"14","author":"RS Rector","year":"2008","unstructured":"Rector RS, Thyfault JP, Wei Y, Ibdah JA (2008) Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 14:185\u2013192","journal-title":"World J Gastroenterol"},{"key":"4429_CR167","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection E, Treatment of High Blood Cholesterol in A","year":"2001","unstructured":"Expert Panel on Detection E, Treatment of High Blood Cholesterol in A (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol In adults (adult treatment panel III). JAMA 285:2486\u20132497","journal-title":"JAMA"},{"issue":"Suppl 1","key":"4429_CR168","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1463-1326.2007.00764.x","volume":"9","author":"KG Alberti","year":"2007","unstructured":"Alberti KG (2007) Screening and diagnosis of prediabetes: where are we headed? Diabetes Obes Metab 9(Suppl 1):12\u201316","journal-title":"Diabetes Obes Metab"},{"key":"4429_CR169","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640\u20131645","journal-title":"Circulation"},{"key":"4429_CR170","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539\u2013553","journal-title":"Diabet Med"},{"key":"4429_CR171","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A","year":"2002","unstructured":"National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A (2002) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106:3143\u20133421","journal-title":"Circulation"},{"key":"4429_CR172","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J, Group IDFETFC (2005) The metabolic syndrome\u2014a new worldwide definition. Lancet 366:1059\u20131062","journal-title":"Lancet"},{"key":"4429_CR173","doi-asserted-by":"publisher","DOI":"10.2174\/1871530317666170320105221","author":"AP Delitala","year":"2017","unstructured":"Delitala AP, Fanciulli G, Pes GM, Maioli M, Delitala G (2017) Thyroid hormones, metabolic syndrome and its components. Endocr Metab Immune Disord Drug Targets. doi: 10.2174\/1871530317666170320105221","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"4429_CR174","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00404-015-3976-7","volume":"293","author":"M Niafar","year":"2016","unstructured":"Niafar M, Pourafkari L, Porhomayon J, Nader N (2016) A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries. Arch Gynecol Obstet 293:509\u2013515","journal-title":"Arch Gynecol Obstet"},{"key":"4429_CR175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.medcli.2015.06.020","volume":"146","author":"M Fernandez-Miro","year":"2016","unstructured":"Fernandez-Miro M, Chillaron JJ, Pedro-Botet J (2016) Testosterone deficiency, metabolic syndrome and diabetes mellitus. Med Clin (Barc) 146:69\u201373","journal-title":"Med Clin (Barc)"},{"key":"4429_CR176","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","volume":"91","author":"DA Ehrmann","year":"2006","unstructured":"Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN et al (2006) Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 91:48\u201353","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR177","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","volume":"91","author":"AD Coviello","year":"2006","unstructured":"Coviello AD, Legro RS, Dunaif A (2006) Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab 91:492\u2013497","journal-title":"J Clin Endocrinol Metab"},{"key":"4429_CR178","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","volume":"18","author":"E Diamanti-Kandarakis","year":"2007","unstructured":"Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP (2007) Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 18:280\u2013285","journal-title":"Trends Endocrinol Metab"},{"key":"4429_CR179","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/BF03347535","volume":"27","author":"E Diamanti-Kandarakis","year":"2004","unstructured":"Diamanti-Kandarakis E, Alexandraki K, Bergiele A, Kandarakis H, Mastorakos G, Aessopos A (2004) Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance. J Endocrinol Invest 27:931\u2013936","journal-title":"J Endocrinol Invest"},{"key":"4429_CR180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1196\/annals.1365.015","volume":"1092","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Paterakis T, Kandarakis HA (2006) Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci 1092:175\u2013186","journal-title":"Ann N Y Acad Sci"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-017-4429-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-017-4429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-017-4429-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T10:00:17Z","timestamp":1569492017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-017-4429-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,22]]},"references-count":180,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["4429"],"URL":"https:\/\/doi.org\/10.1007\/s00404-017-4429-2","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,22]]}}}